Azacitidine belongs to anti-cancer therapy of Oncology Division.
*To be consumed as directed by physician.
Usage Instructions
Azashine is indicated for treatment of patients with the myelodysplastic syndrome subtypes: Refractory anemia or refractory anemia with ringed sideroblasts, Refractory anemia with excess blasts, in transformation, and chronic myelomonocytic leukemia.
